How patients' expectations relate to lingering symptoms after early Lyme disease
Studies whether expectations before antibiotic treatment relate to later symptoms in adults with erythema migrans.
Key facts
- Who runs it
- University Medical Centre Ljubljana
- Where
- Slovenia1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Patient's Pretreatment Expectations About Post-Lyme Symptoms
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 1 Jun 2018
- Expected to end
- 1 Dec 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Antibiotics (preferentially oral doxycycline 100 mg bid)
- Record updated
- 29 April 2026
Who can take part
The trial is looking for adults with early Lyme disease that shows as erythema migrans, a spreading red skin rash after a tick bite. It also includes control people of similar age who never had Lyme disease.
- Age
- 18 Years and older
- Sex
- All sexes can join
- Disease stage
- Early Lyme disease shown as erythema migrans (red skin rash)
- Earlier treatment
- People who took an antibiotic that works against Borrelia within 10 days cannot join
- Main reasons for not taking part
- Pregnancy
- Breastfeeding
- Weakened immune system
- Antibiotic against Borrelia taken within 10 days
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- erythema migrans
Who cannot take part
- pregnancy or lactation
- immunocompromised
- taking antibiotic with antiborrelial activity within 10 days
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Erythema migrans
This trial is currently available in Slovenia.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The investigators will focus on pretreatment expectations of patients with early Lyme disease manifested as erythema migrans with the aim of assessing the association between pretreatment expectations quantified with a questionnaire and treatment outcome quantified with the presence of post-Lyme symptoms. Furthermore, the investigators will compare the prevalence of nonspecific symptoms among patients and among age-matched controls without a history of Lyme borreliosis.
The 2 groups in the trial
- patients with erythema migransExisting treatment, for comparison
Patients will be treated with antibiotics for Lyme disease.
Treatment: Antibiotics (preferentially oral doxycycline 100 mg bid)
- controlsNo study treatment, for comparison
Control subjects will not be given antibiotics.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Patient's Pretreatment Expectations on Treatment Outcome of Early Lyme Borreliosis
- Plain-language title
- How patients' expectations relate to lingering symptoms after early Lyme diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT03462329, who can take part
- Record updated
- 29 April 2026